A Phase III Study of SI-6603 in Patients with Lumbar Disc Herniation

Trial Profile

A Phase III Study of SI-6603 in Patients with Lumbar Disc Herniation

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Sep 2014

At a glance

  • Drugs Condoliase (Primary)
  • Indications Intervertebral disc displacement
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 18 Sep 2014 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan
    • 05 Jun 2014 According to the Seikagaku Corporation media release, results from this trial presented at the 41st Annual Meeting of the International Society for the Study of the Lumbar Spine on 4 June 2014.
    • 12 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top